Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fresh Tracks Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Fresh Tracks Therapeutics

Fresh Tracks Therapeutics

Closed

Boulder-based Fresh Tracks Therapeutics develops drugs for autoimmune, inflammatory, and debilitating diseases.

HQ
Boulder, CO, US
Founded
2009
Overview
Compare
Employees
Website

Founded in Boulder, Colorado, Fresh Tracks Therapeutics is a pharmaceutical company dedicated to developing innovative therapeutics for autoimmune, inflammatory, and debilitating diseases. The company's core mission is to improve the quality of life for patients suffering from these conditions through cutting-edge drug development. Their vision is to lead the field in creating effective treatments that address unmet medical needs, thereby transforming patient care and outcomes.

Notable affiliated individuals and investors have supported Fresh Tracks Therapeutics in its mission. The company has made significant strides in its research and development efforts, contributing to the broader medical community's understanding and treatment of complex diseases. Despite recent challenges, including a petition filed for the appointment of a custodian for eventual dissolution, Fresh Tracks Therapeutics has left a lasting impact on the pharmaceutical industry through its commitment to addressing critical health issues.

Fresh Tracks Therapeutics - Similar Companies

Chase Therapeutics logo

Chase Therapeutics

Aristea Therapeutics logo

Aristea Therapeutics

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Exalys Therapeutics logo

Exalys Therapeutics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Travere Therapeutics logo

Travere Therapeutics

travere.com

Traverse Biosciences logo

Traverse Biosciences

Denali Therapeutics logo

Denali Therapeutics

Forward Therapeutics logo

Forward Therapeutics

forward-tx.com

Complexa logo

Complexa

Theracos logo

Theracos

theracos.com

Biomarck Pharmaceuticals logo

Biomarck Pharmaceuticals

Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

ospreypharma.com

Fulcrum Therapeutics logo

Fulcrum Therapeutics

fulcrumtx.com

Fresh Tracks Therapeutics - Quick Facts

Who are Fresh Tracks Therapeutics' competitors?

Companies similar to Fresh Tracks Therapeutics include Chase Therapeutics, Aristea Therapeutics, Astria Therapeutics and PTC Therapeutics.

When was Fresh Tracks Therapeutics founded?

Fresh Tracks Therapeutics was founded in 2009.

Where is Fresh Tracks Therapeutics' headquarters located?

Fresh Tracks Therapeutics' headquarters is located in Boulder, CO, US.

Fresh Tracks Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research